Empower Advisory Group
LLY icon

Empower Advisory Group’s Eli Lilly LLY Stock Holding History

Empower Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239M Buy
259,772
+10,171
+4% +$10.3M 0.62% 32
2025
Q4 		$268M Buy
249,601
+4,005
+2% +$3.83M 0.72% 31
2025
Q3 		$187M Buy
245,596
+19,662
+9% +$14.6M 0.52% 34
2025
Q2 		$176M Buy
225,934
+13,415
+6% +$10.4M 0.53% 36
2025
Q1 		$176M Buy
212,519
+19,033
+10% +$15.8M 0.57% 33
2024
Q4 		$149M Buy
193,486
+54,212
+39% +$44.9M 0.5% 37
2024
Q3 		$123M Buy
139,274
+5,682
+4% +$5.11M 0.42% 49
2024
Q2 		$121M Buy
133,592
+7,702
+6% +$6.16M 0.45% 44
2024
Q1 		$97.9M Buy
125,890
+93,736
+292% +$66.7M 0.37% 60
2023
Q4 		$18.7M Sell
32,154
-2,192
-6% -$1.28M 0.07% 131
2023
Q3 		$18.4M Sell
34,346
-1,625
-5% -$837K 0.08% 124
2023
Q2 		$16.9M Sell
35,971
-834
-2% -$350K 0.07% 131
2023
Q1 		$12.9M Buy
+36,805
New +$12.4M 0.06% 147

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Empower Advisory Group's LLY Position: Q1 2026 in Review

Empower Advisory Group increased its Eli Lilly (LLY) stake by 4.1% in Q1 2026, buying an estimated $10.3M and bringing the position to 259,772 shares worth $239M. The position accounts for 0.62% of the portfolio, ranked #32.

Empower Advisory Group first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $268M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Empower Advisory Group held 259,772 shares of Eli Lilly worth $239M as of Q1 2026.
  • Empower Advisory Group bought 10,171 Eli Lilly shares in Q1 2026, an estimated $10.3M.
  • Eli Lilly made up 0.62% of Empower Advisory Group's portfolio in Q1 2026, its #32 holding.
  • Empower Advisory Group first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Eli Lilly position peaked at $268M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.